Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Scott Paxton

Hospice and Palliative Medicine Sheboygan Falls, WI Doctor of Osteopathy

NPI 1548246242 CMS profile 492855

W2850 State Road 28, Sheboygan Falls, WI 53085

Open in the dashboard

General payments

$8,414

20 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Scott Paxton of Sheboygan Falls, WI is reported in the CMS Open Payments database as having received $8,414 across 20 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Hospice and Palliative Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $60 1
2024 General $378 7
2023 General $140 1
2022 General $6,050 2
2021 General $1,656 8
2019 General $129 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Paxton
  • Hospice and Palliative Medicine median
  • Middle half of Hospice and Palliative Medicine
  • National median

In program year 2025, general payments to Scott Paxton were reported at $60. Among 151 Hospice and Palliative Medicine profiles paid that year, the median was $79 and the middle half received between $28 and $179.

Show as a table
Year Scott Paxton Hospice and Palliative Medicine median Middle half National median
2019 $129 $70 $20–$164 $163
2020 $0 $67 $19–$171 $114
2021 $1,656 $81 $22–$170 $132
2022 $6,050 $92 $29–$229 $149
2023 $140 $98 $33–$185 $160
2024 $378 $68 $24–$170 $164
2025 $60 $79 $28–$179 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Catalyst OrthoScience $6,341 4 payments
  2. Stryker Corporation $1,947 14 payments
  3. Smith+Nephew, Inc. $65 1 payment
  4. Zimmer Biomet Holdings, Inc. $60 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $6,050 2 payments
  2. Travel and Lodging $1,431 5 payments
  3. Food and Beverage $933 13 payments
Products named General payments · program years 2019–2025
  1. Catalyst Total CSR $6,179 3 payments
  2. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $1,947 14 payments
  3. Archer CSR Total Shoulder System $162 1 payment
  4. Archer R1 Reverse Shoulder System $162 1 payment
  5. AETOS Shoulder System $65 1 payment
  6. COMPREHENSIVE $60 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 52 drugs

Part D claims

1,625

Median for Hospice and Palliative Care: 260

Drug cost

$44,386

Median for Hospice and Palliative Care: $10,445

Branded share of claims

12.4%

Median for Hospice and Palliative Care: 16.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 16 $9,306
Combivent Respimat Ipratropium/Albuterol Sulfate Brand 12 $6,234
Sucralfate Generic 21 $3,450
Levetiracetam Generic 55 $2,036
Novolin 70-30 Flexpen Insulin Nph Hum/Reg Insulin Hm Brand 16 $1,831
Gabapentin Generic 101 $1,579
Quetiapine Fumarate Generic 84 $1,286
Oxycodone Hcl Generic 39 $1,145
Bumetanide Generic 34 $956
Silodosin Generic 11 $948

The 10 drugs with the highest cost, of 52 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,124 Part D prescribers listed as Hospice and Palliative Care; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 9 billing codes

Paid by Medicare

$3,306

Medicare's payments for the services billed

Medicare patients

25

Average age 80

Services billed

29

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 72%
Depression 60%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

20 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hospice and Palliative Medicine in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record